The company has Price/Earnings To Growth (PEG) ratio of 1.74. Edwards Lifesciences Corporation had not issued any dividends in recent years. This company had 2:1 split on 2015-12-14. Edwards Lifesciences Corporationration offer solutions and technologies to treat structural heart disease and critically ill patients worldwide. To learn more about EDWARDS LIFESCIEN call Michael Mussallem at 949 250-2500 or check out www.edwards.com.
(1,256) and Mean Deviation of 1.11. Edwards Lifesciences technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm future prices. In plain English you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum or the prices will eventually revert. We found nineteen technical drivers for Edwards Lifesciences Corporation which can be compared to its rivals. Please confirm Edwards Lifesciences Information Ratio, Potential Upside as well as the relationship between Potential Upside and Kurtosis to decide if Edwards Lifesciences is priced favorably providing market reflects its regular price of 104.98 per share. Given that Edwards Lifesciences has Jensen Alpha of (0.065155), we urge you verify Edwards Lifesciences Corporation prevailing market performance to make sure the company can sustain itself at future point.
Edwards Lifesciences Alerts
Edwards Lifesciences Upcoming Events
Edwards Lifesciences EPS Estimate
Edwards Lifesciences SEC Filings
Market CapitalizationThe company currently falls under 'Large-Cap' category with market capitalization of 22.66 B.
ProfitablityThe company has Net Profit Margin (PM) of 22.16 % which may suggest that it has a good control over its expenditures, executes well on its competitive polices, or have a solid pricing strategies. This is very large. Likewise, it shows Net Operating Margin (NOM) of 29.95 % which signify that for every $100 of sales it has a net operating income of 0.3.
Management EfficiencyEdwards Lifesciences Corporation has Return on Asset (ROA) of 13.17 % which means that for every $100 of asset it generated profit of $13.17. This is typical in the industry. Likewise, it shows return on total equity (ROE) of 26.47 % which means that it produced $26.47 on every 100 dollars invested by current stockholders.
Stock Holders for Edwards Lifesciences
Technical DriversEdwards Lifesciences Corporation shows Coefficient Of Variation of
Edwards Lifesciences Price Movement Analysis